The HIV-1 Vpu protein: A multifunctional enhancer of viral particle release

Microbes and Infection

Volumn 5, Issue 11, 2003, Pages 1029-1039

  Bour, Stephan ^a   Strebel, Klaus ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Accessory genes; HIV; Vpu

Indexed keywords

CD4 RECEPTOR; ION CHANNEL; RECEPTOR; UNCLASSIFIED DRUG; VPU PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CROSS LINKING; CYTOPLASM; ENZYME ACTIVITY; GENE LOCATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR EVOLUTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; T LYMPHOCYTE; VIRUS GENE; VIRUS LOAD; VIRUS PARTICLE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0041570003     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00191-6     Document Type: Review

References (93)

1. Fan L., Peden K. Cell-free transmission of Vif mutants of HIV-1. Virology. 190:1992;19-29.
2. Strebel K., Klimkait T., Martin M.A. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science. 241:1988;1221-1223.
3. Bour S., Strebel K. HIV accessory proteins: multifunctional components of a complex system. Adv. Pharmacol. 48:2000;75-120.
4. Huet T., Cheynier R., Meyerhans A., Roelants G., Wain-Hobson S. Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature. 345:1990;356-359.
5. Courgnaud V., Salemi M., Pourrut X., Mpoudi-Ngole E., Abela B., Auzel P., Bibollet-Ruche F., Hahn B., Vandamme A.M., Delaporte E., Peeters M. Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny. J. Virol. 76:2002;8298-8309.
6. Ritter G.D. Jr., Yamshchikov G., Cohen S.J., Mulligan M.J. Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain. J. Virol. 70:1996;2669-2673.
7. Bour S., Schubert U., Peden K., Strebel K. The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? J. Virol. 70:1996;820-829.
8. Bour S., Strebel K. The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. J. Virol. 70:1996;8285-8300.
9. Schwartz S., Felber B.K., Fenyo E.M., Pavlakis G.N. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J. Virol. 64:1990;5448-5456.
10. Korber B., Foley B., Leitner T., McCutchan F., Hahn B., Mellors J.W., Myers G., Kuiken C. Human Retroviruses and AIDS. Theorical Biology and Biophysics. 1997;Los Alamos National Laboratory, Los Alamos.
11. Schubert U., Bour S., Willey R.L., Strebel K. Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env. J. Virol. 73:1999;887-896.
12. Cohen E.A., Terwilliger E.F., Sodroski J.G., Haseltine W.A. Identification of a protein encoded by the vpu gene of HIV-1. Nature. 334:1988;532-534.
13. Schubert U., Henklein P., Boldyreff B., Wingender E., Strebel K., Porstmann T. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J. Mol. Biol. 236:1994;16-25.
14. Henklein P., Schubert U., Kunert O., Klabunde S., Wray V., Kloppel K. D., Kiess M., Portsmann T., Schomburg D. Synthesis and characterization of the hydrophilic C-terminal domain of the human immunodeficiency virus type 1-encoded virus protein U (Vpu). Pept. Res. 6:1993;79-87.
15. Federau T., Schubert U., Flossdorf J., Henklein P., Schomburg D., Wray V. Solution structure of the cytoplasmic domain of the human immunodeficiency virus type 1 encoded virus protein U (Vpu). Int. J. Pept. Protein Res. 47:1996;297-310.
16. Wray V., Federau T., Henklein P., Klabunde S., Kunert O., Schomburg D., Schubert U. Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and 1H NMR spectroscopy. Int. J. Pept. Protein Res. 45:1995;35-43.
17. Willbold D., Hoffmann S., Rosch P. Secondary structure and tertiary fold of the human immunodeficiency virus protein U (Vpu) cytoplasmic domain in solution. Eur. J. Biochem. 245:1997;581-588.
18. Marassi F.M., Ma C., Gratkowski H., Straus S.K., Strebel K., Oblatt-Montal M., Montal M., Opella S.J. Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1. Proc. Natl. Acad. Sci. USA. 96:1999;14336-14341.
19. Wray V., Kinder R., Federau T., Henklein P., Bechinger B., Schubert U. Solution structure and orientation of the transmembrane anchor domain of the HIV-1-encoded virus protein U by high-resolution and solid-state NMR spectroscopy. Biochemistry. 38:1999;5272-5282.
20. Henklein P., Kinder R., Schubert U., Bechinger B. Membrane interactions and alignment of structures within the HIV-1 Vpu cytoplasmic domain: effect of phosphorylation of serines 52 and 56. FEBS Lett. 482:2000;220-224.
21. Coadou G., Evrard-Todeschi N., Gharbi-Benarous J., Benarous R., Girault J.P. HIV-1 encoded virus protein U (Vpu) solution structure of the 41-62 hydrophilic region containing the phosphorylated sites Ser52 and Ser56. Int. J. Biol. Macromol. 30:2002;23-40.
22. Maldarelli F., Chen M.Y., Willey R.L., Strebel K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 67:1993;5056-5061.
23. Bour S., Geleziunas R., Wainberg M.A. The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in the promotion of HIV-1 infection. Microbiol. Rev. 59:1995;63-93.
24. Crise B., Buonocore L., Rose J.K. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J. Virol. 64:1990;5585-5593.
25. Jabbar M.A., Nayak D.P. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane. J. Virol. 64:1990;6297-6304.
26. Bour S., Boulerice F., Wainberg M.A. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1. J. Virol. 65:1991;6387-6396.
27. Buonocore L., Rose J.K. Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat. Proc. Natl. Acad. Sci. USA. 90:1993;2695-2699.
28. Buonocore L., Rose J.K. Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature. 345:1990;625-628. (see comments).
29. Willey R.L., Maldarelli F., Martin M.A., Strebel K. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 66:1992;226-234.
30. Willey R.L., Maldarelli F., Martin M.A., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66:1992;7193-7200.
31. Chen M.Y., Maldarelli F., Karczewski M.K., Willey R.L., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity. J. Virol. 67:1993;3877-3884.
32. Bour S., Schubert U., Strebel K. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J. Virol. 69:1995;1510-1520.
33. Yao X.J., Friborg J., Checroune F., Gratton S., Boisvert F., Sekaly R.P., Cohen E.A. Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity. Virology. 209:1995;615-623.
34. Vincent M.J., Raja N.U., Jabbar M.A. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum. J. Virol. 67:1993;5538-5549.
35. Lenburg M.E., Landau N.R. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4. J. Virol. 67:1993;7238-7245.
36. Schubert U., Strebel K. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68:1994;2260-2271.
37. Paul M., Jabbar M.A. Phosphorylation of both phosphoacceptor sites in the HIV-1 Vpu cytoplasmic domain is essential for Vpu-mediated ER degradation of CD4. Virology. 232:1997;207-216.
38. Margottin F., Bour S.P., Durand H., Selig L., Benichou S., Richard V., Thomas D., Strebel K. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell. 1:1998;565-574.
39. Spevak W., Keiper B.D., Stratowa C., Castanon M.J. Saccharomyces cerevisiae cdc15 mutants arrested at a late stage in anaphase are rescued by Xenopus cDNAs encoding N-ras or a protein with beta-transducin repeats. Mol. Cell. Biol. 13:1993;4953-4966.
40. Neer E.J., Schmidt C.J., Nambudripad R., Smith T.F. The ancient regulatory-protein family of WD-repeat proteins. Nature. 371:1994;297-300. [published erratum appears in Nature 371 (6500) (1994) 812].
41. Bai C., Sen P., Hofmann K., Ma L., Goebl M., Harper J.W., Elledge S.J. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell. 86:1996;263-274.
42. Schubert U., Anton L.C., Bacik I., Cox J.H., Bour S., Bennink J.R., Orlowski M., Strebel K., Yewdell J.W. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 72:1998;2280-2288.
43. Fujita K., Omura S., Silver J. Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors. J. Gen. Virol. 78:1997;619-625. [published erratum appears in J. Gen. Virol. 78 (Pt 8) (1997) 2129-2130].
44. Yaron A., Hatzubai A., Davis M., Lavon I., Amit S., Manning A.M., Andersen J.S., Mann M., Mercurio F., Ben-Neriah Y. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature. 396:1998;590-594.
45. Winston J.T., Strack P., Beer-Romero P., Chu C.Y., Elledge S.J., Harper J.W. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev. 13:1999;270-283.
46. Spencer E., Jiang J., Chen Z.J. Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP. Genes Dev. 13:1999;284-294.
47. Hatakeyama S., Kitagawa M., Nakayama K., Shirane M., Matsumoto M., Hattori K., Higashi H., Nakano H., Okumura K., Onoe K., Good R.A., Nakayama K. Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc. Natl. Acad. Sci. USA. 96:1999;3859-3863.
48. Hochstrasser M. Protein degradation or regulation: Ub the judge. Cell. 84:1996;813-815.
49. Skowyra D., Koepp D.M., Kamura T., Conrad M.N., Conaway R.C., Conaway J.W., Elledge S.J., Harper J.W. Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1. Science. 284:1999;662-665.
50. Wiertz E.J., Jones T.R., Sun L., Bogyo M., Geuze H.J., Ploegh H.L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell. 84:1996;769-779.
51. Bour S., Perrin C., Akari H., Strebel K. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. J. Biol. Chem. 276:2001;15920-15928.
52. Barkett M., Gilmore T.D. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 18:1999;6910-6924.
53. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 18:1999;6853-6866.
54. Badley A.D., Pilon A.A., Landay A., Lynch D.H. Mechanisms of HIV-associated lymphocyte apoptosis. Blood. 96:2000;2951-2964.
55. Casella C.R., Rapaport E.L., Finkel T.H. Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing. J. Virol. 73:1999;92-100.
56. Akari H., Bour S., Kao S., Adachi A., Strebel K. The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors. J. Exp. M. 194:2001;1299-1311.
57. Klimkait T., Strebel K., Hoggan M.D., Martin M.A., Orenstein J.M. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64:1990;621-629.
58. Strebel K., Klimkait T., Maldarelli F., Martin M.A. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J. Virol. 63:1989;3784-3791.
59. Terwilliger E.F., Cohen E.A., Lu Y.C., Sodroski J.G., Haseltine W.A. Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl. Acad. Sci. USA. 86:1989;5163-5167.
60. Friborg J., Ladha A., Gottlinger H., Haseltine W.A., Cohen E.A. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 8:1995;10-22.
61. Yao X.J., Gottlinger H., Haseltine W.A., Cohen E.A. Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export. J. Virol. 66:1992;5119-5126.
62. Geraghty R.J., Panganiban A.T. Human immunodeficiency virus type 1 Vpu has a CD4- and an envelope glycoprotein-independent function. J. Virol. 67:1993;4190-4194.
63. Schubert U., Bour S., Ferrer-Montiel A.V., Montal M., Maldarell F., Strebel K. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70:1996;809-819.
64. Paul M., Mazumder S., Raja N., Jabbar M.A. Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells. J. Virol. 72:1998;1270-1279.
65. Ewart G.D., Sutherland T., Gage P.W., Cox G.B. The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J. Virol. 70:1996;7108-7115.
66. Callahan M.A., Handley M.A., Lee Y.H., Talbot K.J., Harper J.W., Panganiban A.T. Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. J. Virol. 72:1998;5189-5197. [Erratum appears in J. Virol. 72:8461].
67. Das A.K., Cohen P.W., Barford D. The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR-mediated protein-protein interactions. EMBO J. 17:1998;1192-1199.
68. Handley M.A., Paddock S., Dall A., Panganiban A.T. Association of Vpu-binding protein with microtubules and Vpu-dependent redistribution of HIV-1 Gag protein. Virology. 291:2001;198-207.
69. Deora A., Ratner L. Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation. J. Virol. 75:2001;6714-6718.
70. Schubert U., Ferrer-Montiel A.V., Oblatt-Montal M., Henklein P., Strebel K., Montal M. Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett. 398:1996;12-18.
71. Coady M.J., Daniel N.G., Tiganos E., Allain B., Friborg J., Lapointe J.Y., Cohen E.A. Effects of Vpu expression on Xenopus oocyte membrane conductance. Virology. 244:1998;39-49.
72. Moore P.B., Zhong Q., Husslein T., Klein M.L. Simulation of the HIV-1 Vpu transmembrane domain as a pentameric bundle. FEBS Lett. 431:1998;143-148.
73. Grice A.L., Kerr I.D., Sansom M.S. Ion channels formed by HIV-1 Vpu: a modelling and simulation study. FEBS Lett. 405:1997;299-304.
74. Gottlinger H.G., Dorfman T., Cohen E.A., Haseltine W.A. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA. 90:1993;7381-7385.
75. Bour S.P., Aberham C., Perrin C., Strebel K. Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity. J. Virol. 73:1999;778-782.
76. Clavel F., Guyader M., Guetard D., Salle M., Montagnier L., Alizon M. Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature. 324:1986;691-695.
77. Bour S., Akari H., Miyagi E., Strebel K. Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release. Virology. 309:2003;85-98.
78. McCormick-Davis C., Dalton S.B., Singh D.K., Stephens E.B. Comparison of Vpu sequences from diverse geographical isolates of HIV type 1 identifies the presence of highly variable domains, additional invariant amino acids, and a signature sequence motif common to subtype C isolates. AIDS Res. Hum. Retroviruses. 16:2000;1089-1095.
79. Kusk P., Lindhardt B.O., Bugge T.H., Holmback K., Hulgaard E.F. Mapping of a new immunodominant human linear B-cell epitope on the vpu protein of the human immunodeficiency virus type 1. J. Acquired Immune Defic. Syndr. 6:1993;334-338.
80. Schneider T., Hildebrandt P., Ronspeck W., Weigelt W., Pauli G. The antibody response to the HIV-1 specific "out" (vpu) protein: identification of an immunodominant epitope and correlation of antibody detectability to clinical stages. AIDS Res. Hum. Retroviruses. 6:1990;943-950.
81. Addo M.M., Altfeld M., Rathod A., Yu M., Yu X.G., Goulder P.J., Rosenberg E.S., Walker B.D. HIV-1 Vpu represents a minor target for cytotoxic T lymphocytes in HIV-1-infection. AIDS. 16:2002;1071-1073.
82. Reiss P., Lange J.M., de Ronde A., de Wolf F., Dekker J., Danner S.A., Debouck C., Goudsmit J. Antibody response to viral proteins U (vpu) and R (vpr) in HIV-1-infected individuals. J. Acquired Immune Defic. Syndr. 3:1990;115-122.
83. Yusim K., Kesmir C., Gaschen B., Addo M.M., Altfeld M., Brunak S., Chigaev A., Detours V., Korber B.T. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J. Virol. 76:2002;8757-8768.
84. Stephens E.B., Mukherjee S., Sahni M., Zhuge W., Raghavan R., Singh D.K., Leung K., Atkinson B., Li Z., Joag S.V., Liu Z.Q., Narayan O. A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has offered cytotropism. Virology. 231:1997;313-321.
85. McCormick-Davis C., Zhao L.J., Mukherjee S., Leung K., Sheffer D., Joag S.V., Narayan O., Stephens E.B. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques. Virology. 248:1998;275-283.
86. Li J.T., Halloran M., Lord C.I., Watson A., Ranchalis J., Fung M., Letvin N.L., Sodroski J.G. Persistent infection of macaques with simian-human immunodeficiency viruses. J. Virol. 69:1995;7061-7067.
87. Mackay G.A., Niu Y., Liu Z.Q., Mukherjee S., Li Z., Adany I., Buch S., Zhuge W., McClure H.M., Narayan O., Smith M.S. Presence of Intact vpu and nef genes in nonpathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques. Virology. 295:2002;133-146.
88. Stephens E.B., McCormick C., Pacyniak E., Griffin D., Pinson D.M., Sun F., Nothnick W., Wong S.W., Gunderson R., Berman N.E., Singh D.K. Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques. Virology. 293:2002;252-261.
89. McCormick-Davis C., Dalton S.B., Hout D.R., Singh D.K., Berman N.E., Yong C., Pinson D.M., Foresman L., Stephens E.B. A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques. Virology. 272:2000;112-126.
90. Singh D.K., McCormick C., Pacyniak E., Lawrence K., Dalton S.B., Pinson D.M., Sun F., Berman N.E., Calvert M., Gunderson R.S., Wong S.W., Stephens E.B. A simian human immunodeficiency virus with a nonfunctional Vpu (deltavpuSHIV(KU-1bMC33)) isolated from a macaque with neuroAIDS has selected for mutations in env and nef that contributed to its pathogenic phenotype. Virology. 282:2001;123-140.
91. Bour S., Perrin C., Strebel K. Cell surface CD4 inhibits HIV-1 particle release by interfering with Vpu activity. J. Biol. Chem. 274:1999;33800-33806.
92. Read M.A., Brownell J.E., Gladysheva T.B., Hottelet M., Parent L.A., Coggins M.B., Pierce J.W., Podust V.N., Luo R.S., Chau V., Palombella V.J. Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha. Mol. Cell. Biol. 20:2000;2326-2333.
93. Lopez C.F., Montal M., Blasie J.K., Klein M.L., Moore P.B. Molecular dynamics investigation of membrane-bound bundles of the channel-forming transmembrane domain of viral protein U from the human immunodeficiency virus HIV-1. Biophys. J. 83:2002;1259-1267.